BRCA1-A Complex: A Promising Drug Target and Biomarker for Breast Cancer

Target Name: BRCA1-A complex

NCBI ID: P17075

BRCA1-A complex

Other Name(s): None

BRCA1-A Complex: A Promising Drug Target and Biomarker for Breast Cancer

Breast cancer is a leading cause of cancer-related deaths in women worldwide, with over 280,000 new cases and 56,000 deaths in the United States alone in 2020. The development of effective therapies for breast cancer remains a major challenge, and there is a high demand for new treatments that can offer targeted and effective approaches to disease management. One promising area of research is the identification of drug targets and biomarkers for breast cancer, which can help to improve treatment outcomes and reduce the risk of recurrence. In this article, we will focus on the BRCA1-A complex, which has been identified as a potential drug target and biomarker for breast cancer.

The BRCA1-A Complex

The BRCA1-A complex is a protein complex that is composed of the breast cancer susceptibility gene (BRCA1) and the tumor suppressor gene (BRCA2).BRCA1 and BRCA2 are located on the X chromosome and are responsible for the production of breast milk and the development of breast cancer. The BRCA1-A complex plays a crucial role in the regulation of breast cancer cell growth and division, and it is a key target for drug developers.

The BRCA1-A Complex as a Drug Target

The BRCA1-A complex has been identified as a potential drug target for breast cancer due to its involvement in the regulation of cell growth and division.BRCA1 and BRCA2 are known to play a role in the regulation of cell growth and division by promoting the formation of mitotic spindles, which are important for cell division.Mitotic spindles are made up of microtubules that pull the chromosomes along the spindle during cell division, ensuring that each chromosome is evenly distributed between the two daughter cells.

BRCA1 and BRCA2 also play a role in the regulation of cell cycle progression by activating the G1 checkpoint, which is a critical step in the cell cycle that ensures that cells have enough time to prepare for cell division. Activation of the G1 checkpoint allows cells to enter the S phase of the cell cycle, where DNA replication and cell growth occur.

The BRCA1-A complex has also been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to tissues.BRCA1 and BRCA2 have been shown to promote the formation of blood vessels in breast tissue, which is important for the growth and expansion of breast cancer tumors.

The BRCA1-A Complex as a Biomarker

The BRCA1-A complex has also been identified as a potential biomarker for breast cancer due to its involvement in the regulation of cell growth and division.BRCA1 and BRCA2 are known to be involved in the regulation of cell cycle progression, and therefore, their levels or dysfunction may be an indicator of the severity and stage of breast cancer.

Studies have shown thatBRCA1 and BRCA2 levels are often elevated in breast cancer tissues, and that these levels can be used as a biomarker for disease progression.BRCA1-A complex has also been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to tissues.BRCA1 and BRCA2 have been shown to promote the formation of blood vessels in breast tissue, which is important for the growth and expansion of breast cancer tumors.

Conclusion

In conclusion, the BRCA1-A complex has been identified as a potential drug target and biomarker for breast cancer.BRCA1 and BRCA2 are known to play a role in the regulation of cell growth and division, and the BRCA1-A complex has also been shown to promote the formation of blood vessels in breast tissue, which is important for the growth and expansion of breast cancer tumors.Further research is needed to

Protein Name: BRCA1-A Complex

The "BRCA1-A complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BRCA1-A complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets